Clinical Guidelines

Skin cancer and precancerous skin lesions

• Actinic keratosis (BAD, 2017)
• Basal cell carcinoma (BAD, 2021)
• Kaposi sarcoma (European consensus, 2019)
• Melanoma: Diagnostics (European consensus, 2022)
• Melanoma: Treatment (European consensus, 2022)
• Melanoma: Assessment and Management (NICE, 2015 (updated 2022))
• Melanoma (BAD and Royal College of Physicians, 2007)
• Primary cutaneous lymphomas (BAD, 2018)
• Squamous cell carcinoma (BAD, 2020)
• Squamous cell carcinoma in situ (BAD, 2022)
• Squamous cell carcinoma in solid organ transplant recipients (Stasko, et al., 2004)

Skin cancer prevention and surveillance

• Skin cancer advice for organ transplant recipients (BAD, 2024)
• Prevention of SCC in solid organ transplant recipients (International Delphi Consensus, 2017)
• Skin cancer prevention (NICE, 2011 (updated 2016)
• Skin cancer surveillance in solid organ transplant recipients (US Delphi Consensus, 2019)
• Sunlight exposure: risks and benefits (NICE, 2016)

Cutaneous infection

• Cutaneous warts (BAD, 2014)
• Onychomycosis (BAD, 2014)

Skin Toxicities associated with Cancer Treatments

• Common Terminology Criteria for Adverse Events Grading and Management Escalation Pathway
• Skin toxicities related to anticancer agents (Lacouture, et al., 2020)
• Skin toxicities related to immune checkpoint inhibitors (Kawsar, et al., 2023)
• Immunotherapy Cutaneous Toxicity Guidelines (Kindly provided by Dr Andy Muinonen-Martin (Leeds Teaching Hospital), with Melanoma Focus guidelines due to be published this year.)

Immunosupression related guidelines

• Immunisation Guidance for Adults Treated with Immunosuppressants | Right Decisions